- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
Aren't we seeing continued long-term trend of anti-obesity plays? Health food, organic food and beyond are in for the long-term. This was a big theme in Get Rich Carefully. So have you been scratching your head about the almost-20% decline in Whole Foods yesterday to the high $30s, not to mention the long decline since it stood at over $60 back in November....
If you want to understand why Disney is a stock you can buy for kids and hold over the long term, it's because the company is staying ahead of the game by constantly transforming itself.
The combination of high valuation, no or low profitability and high spending are no longer getting a free pass in this market. Beware of the rotation. It is powerful and will give you whiplash if you dig in your heels and focus on the fundamentals...
The bottom line? We haven't seen a huge amount of M&A this year, but it always key to recognize the winners when they come....
As a follow-up to my previous post, am including a more in-depth analysis of the aftermarket performance of IPOs. As has been noted, plaguing the markets year to date has been the bloodbath in the momentum names--particularly names with no earnings. One thesis regarding the pain in these names is the simple law of supply and demand. Simply put, there is just too much supply....Just look at these aftermarket returns...
How wrinkle reduction is at the crux of the recent M&A frenzy....
There has been a lot of debate of late about whether some of the pain in the so-called momentum names in the last month has something to do with growth money coming into the IPO space...
Talk about whiplash. Yesterday's surge upward was met today with, well, a selloff. So, what gives? What's happening here.
This junior growth name still has much room to run based on market potential and new roll-outs.
Even after a lackluster quarter, future remains bright for FedEx